Back
Biogen Vs. Dave Industry Stock Comparison
Sell
43
BIIB
Biogen
Last Price:
$126.07
Seasonality Move:
7.79%
Buy
90
DAVE
Dave
Last Price:
$249.29
Seasonality Move:
-4.85%
Sell
43
Biogen (BIIB)
is a Sell
Is Biogen a Buy, Sell or Hold?
-
BIIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
DAVE Stock Price Chart
BIIB Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.28 | Sell |
Relative Strength Index (14 RSI): | 45.14 | Sell |
Chaikin Money Flow: | -701496 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (126.46 - 132.5) | Sell |
Bollinger Bands (100): | (121.51 - 140.65) | Sell |
DAVE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 15.72 | Buy |
Relative Strength Index (14 RSI): | 69.64 | Buy |
Chaikin Money Flow: | 180113 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (202.75 - 230.19) | Buy |
Bollinger Bands (100): | (76.33 - 188.57) | Buy |
BIIB Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 126.44 | Sell |
20-day SMA: | 129.82 | Sell |
50-day SMA: | 125.28 | Buy |
200-day SMA: | 149.61 | Sell |
8-day EMA: | 127.18 | Sell |
20-day EMA: | 128.11 | Sell |
50-day EMA: | 128.36 | Sell |
200-day EMA: | 150.36 | Sell |
DAVE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 222.38 | Buy |
20-day SMA: | 219.06 | Buy |
50-day SMA: | 172.27 | Buy |
200-day SMA: | 99.96 | Buy |
8-day EMA: | 229.72 | Buy |
20-day EMA: | 216.55 | Buy |
50-day EMA: | 182.76 | Buy |
200-day EMA: | 113.67 | Buy |
Biogen Earnings Growth & BIIB Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.21 per share, an increase next quarter of $0.05 per share, a decrease this year of $1.55 per share, and an increase next year of $0.64 per share.
Dave Earnings Growth & DAVE Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.35 per share, an increase next quarter of $0.53 per share, an increase this year of $4.51 per share, and an increase next year of $1.19 per share.
Biogen Technical Analysis
Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Dave Technical Analysis
Jun 13 | Jun 16 | Jun 17 | Jun 18 | Jun 20 | Jun 23 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | ||||||||||
13 | 16 | 17 | 18 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |